The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-Induced Hepatitis in Mice

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Shao, Xueting ^a   Qian, Yun ^a   Xu, Chenhuai ^a   Hong, Bo ^b   Xu, Wanhong ^c   Shen, Ling ^a   Jin, Changzhong ^a   Wu, Zhigang ^a   Tong, Xiangmin ^a   Yao, Hangping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Hangzhou High Throughput Drug Screening Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMINOTRANSFERASE; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN INTERLEUKIN 4 FUSION PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE; HEPATOCYTE TRANSPLANTATION; IN VITRO GENE TRANSFER; INTERLEUKIN 18 BINDING PROTEIN GENE; INTERLEUKIN 4 GENE; LIVER HISTOLOGY; LIVER HOMOGENATE; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; VIRAL GENE THERAPY; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; CELL LINE; CELL TRANSPLANTATION; CONCANAVALIN A; CYTOKINES; DRUG-INDUCED LIVER INJURY; FETUS; HEPATITIS; HEPATOCYTES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 84874861922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058836     Document Type: Article

References (47)

1. Massaguer A, Perez-Del-Pulgar S, Engel P, Serratosa J, Bosch J, et al. (2002) Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin. J Leukoc Biol 72: 262-270.
2. Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, et al. (2005) T cell immunity in autoimmune hepatitis. Autoimmun Rev 4: 315-321.
3. Yin H, Cheng L, Agarwal C, Agarwal R, Ju C, (2010) Lactoferrin protects against concanavalin A-induced liver injury in mice. Liver Int 30: 623-632.
4. Tiegs G, Hentschel J, Wendel A, (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 90: 196-203.
5. Fujino M, Kawasaki M, Funeshima N, Kitazawa Y, Kosuga M, et al. (2003) CrmA gene expression protects mice against concanavalin-A-induced hepatitis by inhibiting IL-18 secretion and hepatocyte apoptosis. Gene Ther 10: 1781-1790.
6. Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, et al. (1997) Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 159: 1537-1542.
7. Hu XD, Jiang SL, Liu CH, Hu YY, Liu C, et al. (2010) Preventive effects of 1,25-(OH)2VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression. Acta Pharmacol Sin 31: 703-708.
8. Brown MA, Hural J, (1997) Functions of IL-4 and control of its expression. Crit Rev Immunol 17: 1-32.
9. Fiorentino DF, Bond MW, Mosmann TR, (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095.
10. Kawayama T, Okamoto M, Imaoka H, Kato S, Young HA, et al. (2012) Interleukin-18 in Pulmonary Inflammatory Diseases. J Interferon Cytokine Res. 32: 443-449.
11. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, et al. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136.
12. Leng J, Yao H, Shen J, Wang K, Zhuo G, et al. (2008) Co-expression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim Biophys Sin (Shanghai) 40: 116-124.
13. Yao HP, Qian Y, Shao XT, Xu ZR, Cheng LF, et al. (2010) Construction of a recombinant adenovirus vector expressing IL-18BP/IL-4 fusion gene and the anti-inflammatory effect induced by this gene on lipopolysaccharide-stimulated synovial fibroblasts. Inflamm Res 59: 97-104.
14. Sarra GM, Stephens C, Schlichtenbrede FC, Bainbridge JW, Thrasher AJ, et al. (2002) Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res 42: 541-549.
15. Cao X, Zhang W, Wang J, (1996) Augmentation of liver immune functions by intrasplenic transplantation of IL-2 gene-modified hepatocytes. Nail Med J Chin (Chin) 76: 646-649.
16. Zhang L, Mi J, Yu Y, Yao H, Chen H, et al. (2001) IFN-gamma gene therapy by intrasplenic hepatocyte transplantation: a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice. Parasite Immunol 23: 11-17.
17. Zhang W, Cao X, Huang X, Wang J, Tao Q, et al. (1997) In vivo distribution and gene expression of genetically modified hepatocytes after intrasplenic transplantation. Sci China C Life Sci 40: 554-560.
18. Zhang LH, Pan JP, Yao HP, Sun WJ, Xia DJ, et al. (2001) Intrasplenic transplantation of IL-18 gene-modified hepatocytes: an effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response. Gene Ther 8: 1333-1342.
19. Qian Y, Shen L, Xu C, Wu Z, Brockmeyer NH, et al. (2011) Development of a novel monoclonal antibody to b7-h4: characterization and biological activity. Eur J Med Res 16: 295-302.
20. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, et al. (1995) A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63: 3966-3972.
21. Kremer L, Dupre L, Wolowczuk I, Locht C, (1999) In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J Immunol 163: 3226-3231.
22. Gupta S, Aragona E, Vemuru RP, Bhargava KK, Burk RD, et al. (1991) Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 14: 144-149.
23. Navarro-Alvarez N, Soto-Gutierrez A, Chen Y, Caballero-Corbalan J, Hassan W, et al. (2010) Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in mice. J Hepatol 52: 211-219.
24. Zhou YC, Chen S, Cao JJ, Chen SY, Xie YF, et al. (2012) Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury. Dig Liver Dis 44: 398-405.
25. Li Y, Wang ZL, He F, Wu Y, Huang W, et al. (2012) TP-58, a novel thienopyridine derivative, protects mice from concanavalinA-induced hepatitis by suppressing inflammation. Cell Physiol Biochem 29: 31-40.
26. Mase A, Makino B, Tsuchiya N, Yamamoto M, Kase Y, et al. (2010) Active ingredients of traditional Japanese (kampo) medicine, inchinkoto, in murine concanavalin A-induced hepatitis. J Ethnopharmacol 127: 742-749.
27. Lavon I, Sheinin T, Meilin S, Biton E, Weksler A, et al. (2003) A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. Mol Pharmacol 64: 1334-1341.
28. Kollias G, Douni E, Kassiotis G, Kontoyiannis D, (1999) On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 169: 175-194.
29. Schümann J, Angermüller S, Bang R, Lohoff M, Tiegs G, (1998) Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J Immunol 161: 5745-5754.
30. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Fiqdor CG, (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76: 1392-1397.
31. Bulau AM, Fink M, Maucksch C, Kappler R, Mayr D, et al. (2011) In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Scientific World Journal 11: 2480-2490.
32. Lamacchia C, Rodriguez E, Palmer G, Vesin C, Seemayer CA, et al. (2012) Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis. Eur J Immunol 42: 1294-1303.
33. Wong HL, Costa GL, Lotze MT, Wahl SM, (1993) Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med 177: 775-781.
34. Van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zvberk C, et al. (2004) Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 6: R239-R249.
35. Yao Y, Li W, Kaplan MH, Chang CH, (2005) Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 201: 1899-1903.
36. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, et al. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154: 5071-5079.
37. Leonard EJ, Yoshimura T, (1990) Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11: 97-101.
38. Grimm MC, Elsbury SK, Pavli P, Doe WF, (1996) Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 59: 804-812.
39. Kucharzik T, Lügering N, Pauels HG, Domschke W, Stoll R, (1998) IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol 111: 152-157.
40. Smeets RL, van de Loo FA, Arntz OJ, Bennink MB, Joosten LA, et al. (2003) Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther 10: 1004-1011.
41. Guha M, Mackman N, (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277: 32124-32132.
42. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, et al. (2000) Toll-like receptor 2-mediated NF-κB activation requires a Rac1-dependent pathway. Nat Immunol 1: 533-540.
43. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, et al. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kB. Mol Cell Biol 20: 1626-1638.
44. Li CY, Chao LK, Wang SC, Chang HZ, Tsai ML, et al. (2011) Honokiol inhibits LPS-induced maturation and inflammatory response of human monocyte-derived dendritic cells. J Cell Physiol 226: 2338-2349.
45. Saccani S, Pantano S, Natoli G, (2002) p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat Immunol 3: 69-75.
46. Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E, (2007) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007: 45673.
47. Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, et al. (2006) The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol 36: 37-45.